ascopubs.org

Rituximab Therapy in Hematologic Malignancy Patients With Circulating Blood Tumor Cells: Association With Increased Infusion-Related Side Effects and Rapid Blood Tumor Clearance

Primary Mediastinal Large B-Cell Lymphoma: A Clinicopathologic Study of 43 Patients From the Nebraska Lymphoma Study Group PURPOSE: Rituximab was recently approved for use in relapsed, low-grade ...
Nasdaq

FDA APPROVES RIABNI™ (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN® (RITUXIMAB), FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS

THOUSAND OAKS, Calif., June 6, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to Rituxan® ...
The American Journal of Managed Care

Rituximab Infusion Timing, Dosing and COVID-19 Hospitalization Not Linked, Study Says

A study examining the relation between rituximab infusion and hospitalization as a result of COVID-19 for patients with multiple sclerosis (MS) found that the 2 were not related, contradicting past ...
Healio

Timing of rituximab infusion not tied to risk for COVID-19 hospitalization

Please provide your email address to receive an email when new articles are posted on . The timing of rituximab infusion or cumulative lifetime rituximab dose did not appear statistically ...
Medscape

Ninety-Minute Rituximab Infusions Can Be Performed Safely in Non-Hodgkin's Lymphoma

May 10, 2007 (Las Vegas) — Rituximab can be safely infused using a rapid 90-minute protocol in patients with non-Hodgkin's lymphoma, according to a presentation made at the annual meeting of the ...
ascopubs.org

Rapid-Infusion Rituximab in Lymphoma Treatment: 2-Year Experience in a Single Institution

Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor ...
Healio

Anti-rituximab antibodies do not affect rituximab impact in idiopathic nephrotic syndrome

Please provide your email address to receive an email when new articles are posted on . The presence of anti-rituximab antibodies does not change the response that pediatric patients with ...
Medscape

Rituximab as Treatment for the Antiphospholipid Antibody Syndrome

The primary manifestation of the antiphospholipid antibody syndrome (APS) is thrombosis, which forms the core of the classification criteria for this syndrome. However, multiple other noncriteria ...
The American Journal of Managed Care

Celltrion Releases First Real-world Data for Its Rituximab Biosimilar in DLBCL

Real-world data confirmed the clinical effectiveness of Celltrion Healthcare’s rituximab biosimilar (Truxima, CT-P10) in patients with diffuse large B-cell lymphoma (DLBCL). The company ran a ...
Renal & Urology News

Rituximab Effective for Relapsing or Steroid-Dependent Nephrotic Syndrome

A trial evaluated whether rituximab can attain remission in adults with frequently relapsing nephrotic syndrome (FRNS) or steroid dependent nephrotic syndrome (SDNS).
UPI

Cancer drug shows promise for treating multiple sclerosis

A drug used "off-label" for multiple sclerosis (MS) is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found. The drug, called rituximab, is ...